The Buck Institute for Research on Aging is getting ready to launch the first-ever clinical trial on the effects of ketone supplementation on frailty after receiving a $3.5 million grant from the National Institutes of Health.
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.